Can Traditional CER Address Resource Allocation?

While the growth in U.S. healthcare costs is receiving substantial attention, many believe that instead of looking at general contributors, i.e. pharmaceutical pricing, we should look to resource allocation. Could Comparative Effectiveness Research (CER) methods help to answer this or is something different needed? Learn more here. (Source: Robert W Dubois, Future Medicine, Nov 2016)

You might also be interested in:

Invoke a 1980's Law to Lower Cost of Remdesivir for COVID-19,… 08/07/2020
Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020
Where Epidemiologists are Leaning on Kids Returning to School 06/14/2020
What Are The Recent Top 4 Innovative Consolidations and… 08/26/2020
ICER Recommendations Can Be Influenced With the Right Evidence 11/19/2020
What is the Current State of Real-World Evidence (RWE) Across… 09/03/2020
Blog Post: Making the Most of Our Health Care Dollars 02/20/2020